Trial Profile

A Study to Investigate the Preventive Effect of AG-1749 Against the Recurrence of Gastric And Duodenal Ulcers During Long-Term Treatment With Low Dose Aspirin.

Status: Completed

Phase of Trial: Phase III

Latest Information Update: 20 May 2016

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs Lansoprazole (Primary) ; Gefarnate
Indications NSAID-induced ulcer
Focus Therapeutic Use
Sponsors Takeda Pharma

Most Recent Events

19 Dec 2008 Actual end date (Nov 2008) added as reported by ClinicalTrials.gov.
19 Dec 2008 Planned number of patients changed from 812 to 461 as reported by ClinicalTrials.gov.
19 Dec 2008 Status changed from recruiting to discontinued as reported by ClinicalTrials.gov.

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com